Fipid
Triple kinase inhibitor nintedanib (marketed as Ofev) is used to treat adults with idiopathic pulmonary fibrosis (IPF), systemic sclerosis associated with fibrosis, and interstitial lung diseases with a progressive fibrosing phenotype.
Therapeutic Area
Pulmonary fibrosis
Active Ingredient
Nintedanib
Line
Rare Diseases
Dosage forms
150 and 100 mg x 60 tablets
